This article is more than 5 years old. Information may no longer be current.
Wright Medical Group, Inc. launches demineralized moldable scaffold
Click Here to Manage Email Alerts
Wright Medical Group, Inc. announced the full commercial launch of their FUSIONFLEX demineralized moldable scaffold, according to a press release. The scaffold is a form of demineralized bone matrix made from 100% allograft and is designed for use in conjunction with hardware in primary fusion procedures of the lower extremities, as well as other bone grafting applications.
“There are an estimated 70,000 mid- and hindfoot fusions performed each year in the United States, with a significant number requiring a biologic adjunct,” stated Eric E. Gay, senior director of upper extremity and biologics with Wright, Inc., in the release. “Following minimal preparation, FUSIONFLEX scaffold readily absorbs biologic agents, such as bone marrow aspirate and platelet-rich plasma, resulting in an intraoperatively-flexible graft at a relatively low cost. We are excited to introduce this graft as a solution for the large number of fusion procedures being performed in both hospital and outpatient settings.”
FUSIONFLEX scaffold builds on Wright’s allograft platform and partnership with AlloSource. The scaffold quickly hydrates and becomes a flexible, absorbent matrix which is compressed to fit into challenging spaces yet robust enough to can expand to match nearly any contour within the space, according to the release.